Schizophrenia Research
Volume 96, Issue 1 , Pages 87-92, November 2007

The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia

  • Faith B. Dickerson

      Affiliations

    • Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System, 6501 North Charles, St., Baltimore, MD, 21204, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 938 4359; fax: +1 410 938 4364.
  • ,
  • John J. Boronow

      Affiliations

    • Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System, 6501 North Charles, St., Baltimore, MD, 21204, USA
  • ,
  • Cassie Stallings

      Affiliations

    • Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System, 6501 North Charles, St., Baltimore, MD, 21204, USA
  • ,
  • Andrea E. Origoni

      Affiliations

    • Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System, 6501 North Charles, St., Baltimore, MD, 21204, USA
  • ,
  • Anne Sullens

      Affiliations

    • Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System, 6501 North Charles, St., Baltimore, MD, 21204, USA
  • ,
  • Robert H. Yolken

      Affiliations

    • Stanley Neurovirology Laboratory, 600 North Wolfe St., Johns Hopkins University School of Medicine, Baltimore, MD, 21207, USA

Received 10 March 2007; received in revised form 12 May 2007; accepted 16 May 2007. published online 09 July 2007.

Abstract 

Background

A valine/methionine polymorphism of the catechol O-methyltransferase gene at the nucleotide which encodes amino acid val or met at position 158 in the protein (COMT Val158Met polymorphism) has been associated with deficits in executive functioning in schizophrenia in some studies. The association between the COMT polymorphism and other cognitive domains has been the focus of only limited investigation.

Methods

We measured COMT Val158Met genotypes in N=364 individuals with schizophrenia. Cognitive functioning was assessed with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). We employed univariate and multivariate analyses of variance to determine the association between COMT genotypes and the RBANS index and individual test scores.

Results

There was no significant association between the COMT Val158Met genotypes and any of the RBANS index or individual test scores measured in either univariate or multivariate analyses (all p>.3).

Conclusion

Based on the results in our sample, the catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.

Keywords: Schizophrenia, Genetic, COMT, Cognition

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(07)00235-6

doi:10.1016/j.schres.2007.05.021

Schizophrenia Research
Volume 96, Issue 1 , Pages 87-92, November 2007